Government flights proposals for Covid-19 vaccine injury claims

A no-fault compensation fund is to be established, as per conditions set by vaccine manufacturers

Zweli Mkhize blames Big Pharma for vaccine delivery delays

The health minister says talks have been lengthy and difficult as the manufacturers of Covid-19 vaccines sought onerous terms

Government pauses use of J&J vaccine pending safety review

Health minister says the pause is a precautionary measure and vaccinations may resume soon

SA mulling whether to pause J&J Covid-19 shot

Extremely rare blood-clotting events have been noted in the US and Europe among the millions who have received the shot so far

Medicines regulator confirms J&J vaccine registration conditions restrict sale to state

Only the national government can purchase and oversee the rollout of vaccines, bypassing the private sector

Risk of Covid-19 third wave within next two weeks is low, say SA researchers

But it is too soon to tell if more social interaction and religious gatherings over the Easter weekend seeded an increase in Covid-19 transmission

WATCH: What an industry-sponsored study has to say about the booze bans

Busa CEO Cas Coovadia talks to Business Day TV about a study’s findings on the necessity of the alcohol bans

State expects first J&J and Pfizer jabs to be delivered in next two weeks

Combined with supplies expected from Pfizer before end-April, this will enable government to finish vaccinating healthcare workers

Zweli Mkhize calls on Africa to step up drug-making capacity

Relying on other countries for medical supplies had hampered Africa’s fight against the Covid-19  pandemic

State nails down Pfizer deal at last as crucial contract signed

Delivery of vaccines from middle of April means scene is set for SA to begin its vaccination programme

J&J vaccine gets conditional approval and Pfizer trial shows great success

The J&J vaccine can now start being used in the general population, while the Pfizer trial shows its vaccine is effective against the B.1.351 variant

Pfizer vaccine protects well against Covid-19 variant found in SA, data shows

While the new overall efficacy rate of 91.3% is lower than the 95% originally reported in November, a number of variants have become more prevalent globally ...

Novavax to be evaluated for SA use

Committee advised against using jab, Zweli Mkhize told portfolio committee on Tuesday

‘It’s in our hands,’ says Discovery Health CEO as third wave looms

Concern growing that slow vaccine rollout, the dominance of a new variant, and cooler weather will combine to potentially deadly effect

Pfizer wants state indemnity before supplying doses

Demand comes after reports that J&J shots will be delayed because government did not sign no-fault clause

Aspen to help J&J deliver 30-million shots to SA

The facility will complete and package 250-million doses for Africa, with 30-million for SA


Published by Arena Holdings and distributed with the Financial Mail on the last Thursday of every month except December and January.